Quoin Pharmaceuticals Ltd (STU:2EB)
€ 6.144 0 (0%) Market Cap: 24.45 Mil Enterprise Value: 12.81 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 19/100

Q4 2022 Quoin Pharmaceuticals Ltd Earnings Call Transcript

Mar 09, 2023 / 01:30PM GMT
Release Date Price: €7.44 (+16.98%)
Operator

Good day and welcome to the Quoin Pharmaceuticals Ltd. fourth-quarter financial results and business update conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Gordon Dunn, Chief Financial Officer. Please go ahead.

Gordon Dunn
Quoin Pharmaceuticals Ltd. - CFO

Thank you and good morning. We appreciate you joining us on today's conference call. With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO.

We're pleased to provide an update on our progress throughout the fourth quarter of 2022 and for the year as a whole and discussing Quoin Pharmaceuticals' financial results. Please note that our operational and financial results' press release is now available on Quoin's website.

To begin, Michael will provide a corporate, clinical, and operational update, following which, I'll review our Q4 and full-year 2022 financial results. I will then hand the call back to Michael for closing comments. We will also be pleased to answer any questions at the end of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot